Claim: Facebook post Says the governors of Michigan, New York and Nevada “have issued orders banning the prescription of hydroxychloroquine to patients with COVID-19.”
Verdict: REFUTES

Retrieved passages:
title: Conscience clause (medicine)
text: Governor Rod Blagojevich by emergency executive order required all pharmacists to provide Plan B levonorgestrel. In September 2012, the Illinois Appellate Court found the Governor’s order violated Illinois law. In June 2006, the Pharmacy Board of the Washington State Department of Health rejected a draft rule proposed by Governor Christine Gregoire to require all pharmacies to begin carrying Plan B. Governor Gregoire responded by releasing a public statement warning the Board members to reconsider or they could be removed. In July 2006, the Washington State Human Rights Commission warned the Board members that they would be personally liable for illegally

title: Cardinal Health
text: that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone. Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA

title: Methylenedioxypyrovalerone
text: as well as three other cathinones, controlled substances in the state. It also makes it a Class A misdemeanor to sell the drug, and a Class B misdemeanor to possess it. MDPV is banned in New Jersey under Pamela's Law. The law is named after Pamela Schmidt, a Rutgers University student, murdered in March 2011 by an alleged user of MDPV. A toxicology report later found that no "bath salts" were present in his system. On May 5, 2011, Tennessee Governor Bill Haslam signed a law making it a crime "to knowingly produce, manufacture, distribute, sell, offer for sale or

title: 2,4-Dichlorophenoxyacetic acid
text: data and deemed them acceptable. On April 18, 2012, EPA denied the petition filed November 6, 2008, by the Natural Resources Defense Council to revoke all tolerances and to cancel all registrations of 2,4-D. EPA stated that recent new study and EPA’s comprehensive review confirmed EPA’s previous finding that the 2,4-D tolerances are safe at anticipated exposure. In October 2014, the US EPA registered Enlist Duo, an herbicide containing the less volatile 2,4-D choline salt, glyphosate, and an antidrift agent, for use in six states: Illinois, Indiana, Iowa, Ohio, South Dakota, and Wisconsin. In November 2015, the EPA attempted to

title: Scott Dozier
text: and Sandoz also objected to the use of their drugs (fentanyl and cisatracurium besilate, respectively) but did not join Alvogen's lawsuit. The next court hearing regarding the case is scheduled for September 10, 2018, in which Alvogen, a pharmaceuticals manufacturer whose drugs were purchased for the execution, is seeking to prevent the use of Midazolam in any lethal injection execution. Alvogen asserts that the Nevada Department of Corrections fraudulently obtained one of its sedatives to be used in the execution, and also filed a temporary restraining order to prevent its product from being used in executions. Lawyers for Alvogen claim

title: Valsartan
text: Accord Healthcare. In Canada, the recall involves five companies and a class action suit has been initiated by a private law firm. Authorities believe the degree of contamination is negligible, and advise those taking the drug to consult a doctor and not to cease taking the medication abruptly. On July 12, 2018, The National Agency of Drug and Food Control (NA-DFC or Badan POM Indonesia) announced voluntary recalls for two products containing valsartan produced by Actavis Indonesia and Dipa Pharmalab Intersains. On July 13, 2018, the FDA announced voluntary recalls of certain supplies of valsartan and valsartan/hydrochlorothiazide (HCTZ) in the

title: Mass drug administration
text: bags. The state held the monopoly for the salt. The only alternative source was salt smuggled from Brazil. Although the chloroquinized salt was used, its popularity was limited by the occurrence of a photo-allergic dermatitis popularly called ‘salt itch’ noted in all treatment areas. Chloroquine resistance was first observed in 1962 in the area with the lowest relative uptake of chloroquinized salt. In the course of the following months, a complete replacement of the susceptible strains with resistant "P. falciparum" strains was observed. Following the reintroduction of DDT spraying, the prevalence of "P. falciparum" declined. In Southeast Asia, the medicated

title: Executive Order 13771
text: chairman and Public Citizen Litigation Group lawyer David Vladeck called the executive order "unconstitutional, illegal and stupid," saying "if you really want to reduce the regulatory load, you can't use a shotgun, you have to use a scalpel." On April 17, 2017, fourteen states (West Virginia, Wisconsin, Alabama, Arizona, Arkansas, Georgia, Kansas, Louisiana, Michigan, Nevada, Oklahoma, South Carolina, Texas, and Wyoming) filed an amici curiae in support of the Executive Order. The Republican states argue that the Executive Order falls within allowed presidential authority and will benefit state governments. In March 2017, the US Patent and Trademark Office (USPTO) formed

title: Mass drug administration
text: 10 of China’s 33 provinces. The drugs used in the administrations, mostly chloroquine and piperaquine, were provided free of charge by the central government. The economic reforms instituted by Deng Xiaoping, which ultimately put an end to the provision of free health care through the central government and the emergence of resistance against the most widely used antimalarials modified the use of mass drug administrations after 1980. MDAs are now targeted at high-risk populations, specifically non-immune migratory workers who receive repeated courses during the high transmission season. According to government guidelines, piperaquine, chloroquine, or sulfadoxine combined with primaquine can be

title: 2,4-Dichlorophenoxyacetic acid
text: withdraw its own approval of Enlist Duo, as a result of legal actions against both the agency and Dow by two U.S. groups. However, while it was implied that the approval was "gone" because of the action, in fact, Enlist Duo was still approved pending a decision by the courts. On January 25, 2016, the US Ninth Circuit Court of Appeals denied EPA's motion to vacate its Enlist Duo registration. Dow stated the product would be available in 15 US states and Canada for the 2016 crop season. On 21 August 2013, the Australian Pesticides and Veterinary Medicines Authority (APVMA)

title: Andrew Cuomo
text: available to 20 designated hospitals for the treatment of cancer and glaucoma. Later in July, New York became the 23rd state to allow the medical use of marijuana, as the Governor signed the Compassionate Care Act, not without drawing the criticism of legalization activists, though. In August 2017, the Cuomo administration awarded more than $7 million - financed with money from large bank settlements - in grants to New York colleges to offer courses to New York prisoners. In January 2018, Cuomo proposed reforms that would "reduce delays during trials, ban asset seizures in cases where there has been no

title: Synthetic cannabinoids
text: Alabama in May 2010, Tennessee and Missouri in July 2010, Louisiana in August 2010, Mississippi in September 2010, and Iowa. An emergency order was passed in Arkansas in July 2010 banning the sale of synthetic cannabis mimics. In October 2010, the Oregon Board of Pharmacy listed synthetic cannabinoid chemicals on its Schedule 1 of controlled substance, which means that the sale and possession of these substances is illegal under the Oregon Uniform Controlled Substances Act. According to the National Conference of State Legislatures, several other states are also considering legislation, including New Jersey, New York, Florida, and Ohio. Illinois passed

title: Politics of Vermont
text: ill, the Democratic-controlled House of Representatives rejected the measure by a vote of 82–63. In 2013, the state passed Assisted Suicide legislation, Act 39. It was the third state to do so. Also in 2007. the governor signed the "Prescription Confidentiality Law", required that records containing a doctor's prescribing practices not be sold or used for marketing purposes unless the doctor consented. This statute was struck down in 2011 by the U.S. Supreme Court in Sorrell v. IMS Health, Inc. as a violation of the First Amendment. In 2009, Vermont passed the strictest law in the nation controlling the marketing

title: Dextromethorphan regulation by state
text: found in violation of this bill is subject to a written warning from law enforcement for the first offense and is guilty of a class 1 civil infraction. This bill took effect July 1, 2015. West Virginia does not have any documented regulation pertaining to the purchase of dextromethorphan available at this time. Wisconsin Assembly Bill 681 states that a provider is prohibited from providing a dextromethorphan containing product to a person under the age of 18 and a person under the age of 18 is prohibited to purchase a dextromethorphan containing product. This part of the bill does not

title: Cardinal Health
text: that Cardinal Health's activities represented an "imminent danger to the public." The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida. In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. Deputy Attorney General James M. Cole then called Rannazzisi to a meeting at Justice Department headquarters

title: Hydrocodone
text: currently available hydrocodone combination products". Thirty U.S. states asked the FDA not to approve Zohydro ER in capsule form due to its potency and the ease with which it could be abused, by being crushed and then snorted or injected. Zohydro ER was briefly prohibited in Massachusetts before a federal judge ruled that the state's ban was preempted by the earlier federal approval. The US government imposed tougher prescribing rules for hydrocodone in 2014, changing the drug from Schedule III to Schedule II. In 2011, hydrocodone products were involved in around 100,000 abuse-related emergency department visits in the United States,

title: Dextropropoxyphene
text: will fall on the prescriber" is unacceptable to most doctors. Some patients intend to take the case to the European Court of Human Rights. However, the European Medicines Agency has recently backed the agency's decision, and recommended in June 2009 that propoxyphene preparations be withdrawn across the European Union. On 28 March 2017, NHS Clinical Commissioners announced that co-proxamol will be no longer available under NHS England as part of £400m of spending cuts for prescriptions that are believed to have little or no clinical value. In January 2009, an FDA advisory committee voted 14 to 12 against the continued

title: Rod Blagojevich
text: Blagojevich issued an executive order during 2004 requiring pharmacists in the state to dispense "morning-after" birth control, even if they object on moral or religious grounds. This order was legally challenged. Later in 2007, opponents of the governor's executive order reached a settlement with the state in one case, causing partial removal of the order. The settlement, which followed the Illinois Supreme Court's decision in September 2007 to hear an appeal of a lawsuit challenging the executive order, allowed pharmacists to decline to dispense birth control, so long as they provided information to customers about pharmacists who did. In another

title: Amodiaquine
text: has also been found to work against chloroquine-resistant "P. falciparum" strains of malaria. There have been reports of increased liver toxicity in people with HIV/AIDS on zidovudine or efavirenz when treated with amodiaquine-containing ACT regimens, therefore it is recommended that these people avoid amodiaquine. It is bioactivated hepatically to its primary metabolite, N-desethylamodiaquine, by the cytochrome p450 enzyme CYP2C8. Among amodiaquine users, several rare but serious side effects have been reported and linked to variants in the CYP2C8 alleles. CYP2C8*1 is characterized as the wild-type allele, which shows an acceptable safety profile, while CYP2C8*2, *3 and *4 all show a

title: Chloroquine retinopathy
text: suggest that lean body weight is more accurate when calculating daily dosage. Most patients are routinely given 400 mg of hydroxychloroquine daily (or 250 mg chloroquine). This dose is considered acceptable. The earliest signs of toxicity include bilateral paracentral visual field changes (best detected with a red test object) and a subtle granular depigmentation of the paracentral RPE. With continued drug exposure, there is progressive development of a bilateral atrophic bull's-eye maculopathy and paracentral scotomata, which may in severe cases ultimately spread over the entire fundus, causing widespread retinal atrophy and visual loss. Both agents bind to melanin pigment in